The impact of sodium-glucose co-transporter-2 inhibitors on serum sodium and potassium in patients with Heart Failure: a systematic review and meta-analysis.
Amani-Beni R, Darouei B, Shafie D, Mortaheb M, Malakoutikhah M, Ebrahimi A, Heidari-Hasanabadi S, Rabiee Rad M, Ghasempour Dabaghi G, Mazaheri-Tehrani S, Amini-Salehi E, Abhari AP, Heidarpour M.
Amani-Beni R, et al.
BMC Cardiovasc Disord. 2025 Apr 3;25(1):252. doi: 10.1186/s12872-025-04704-w.
BMC Cardiovasc Disord. 2025.
PMID: 40181257
Free PMC article.
Sensitivity and subgroup analyses based on duration, drug type, diabetes status, renal function, or systolic blood pressure did not reveal clinically meaningful differences across all analyses. For all analyses, Egger's test was non-significant, indicating no strong eviden …
Sensitivity and subgroup analyses based on duration, drug type, diabetes status, renal function, or systolic blood pressure did not reveal c …